Accessibility Menu
 

Tibet Pharmaceuticals

(OTC) TBET

Current PriceN/A
Market CapN/A
Since IPO (2011)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Tibet Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$34.05M

Net Income (TTM)

$10.82M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

TBET News

No articles available.

TBET: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tibet Pharmaceuticals

Industry

Pharmaceuticals

Headquarters

Wanchai, HK

TBET Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

41%

Net Income Margin

41%

Return on Equity

77%

Return on Capital

57%

Return on Assets

47%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

19.12%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$16.18M

Operating Income

$13.32M

EBITDA

$14.22M

Operating Cash Flow

$7.85M

Capital Expenditure

$150.10K

Free Cash Flow

$7.70M

Cash & ST Invst.

$7.58M

Total Debt

$0.00

Tibet Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2011YOY CHG

Revenue

$8.58M

-4.9%

Gross Profit

$2.95M

-36.8%

Gross Margin

34.31%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

190

N/A

Net Income

$1.65M

-57.1%

EBITDA

$2.02M

-53.0%

Quarterly Fundamentals

Name
Q3 2011YOY CHG

Net Cash

$25.96M

+450.0%

Accounts Receivable

$16.01M

+65.6%

Inventory

$1.74M

-5.6%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

N/A

Return on Assets

46.61%

N/A

Return on Invested Capital

56.70%

N/A

Free Cash Flow

$3.79M

-781.7%

Operating Cash Flow

$3.79M

-779.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GENXGenex Pharmaceutical, Inc.
$0.00+0.00%
OHAQOracle Healthcare Acquisition Corp.
$0.00+0.00%
NMTRQ9 Meters Biopharma, Inc.
$0.00+0.00%
MILCMillennium Sustainable Ventures Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About TBET

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.